Icl Scientific: FDA filings under this applicant name
FDA lists 48 510(k) clearances under the applicant name “Icl Scientific” (first 1976, latest 1988), across 36 product codes in 6 review panels. Median 510(k) review time under this name: 28 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DEW | Igg, Antigen, Antiserum, Control | 4 | 4 |
| JJW | Urinalysis Controls (Assayed And Unassayed) | 3 | 3 |
| CZP | Iga, Antigen, Antiserum, Control | 2 | 2 |
| DAK | Complement C1q, Antigen, Antiserum, Control | 2 | 2 |
| DEH | Lambda, Antigen, Antiserum, Control | 2 | 2 |
| DFH | Kappa, Antigen, Antiserum, Control | 2 | 2 |
| DFT | Igm, Antigen, Antiserum, Control | 2 | 2 |
| DHC | System, Test, Systemic Lupus Erythematosus | 2 | 2 |
| DIF | Drug Mixture Control Materials | 2 | 2 |
| CDP | Radioimmunoassay, Total Triiodothyronine | 1 | 1 |
Plus 26 more product codes.
Review panels
- Immunology (27)
- Clinical Chemistry (12)
- Clinical Toxicology (5)
- Gastroenterology and Urology (1)
- Hematology (1)
- Microbiology (1)
Most recent Icl Scientific 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K883942 | HYCOR SENTRY DRUGS OF ABUSE URINE CONTROL | JJY | 1988-11-10 | 52 |
| K843565 | KOVA TROL I,II, III HUMAN URINE-DRIED | JJW | 1984-10-05 | 25 |
| K833761 | THERAPEUTIC DRUG CONTROL | DKB | 1984-01-13 | 79 |
| K832823 | ENZYMUNE-TEST TSH | JLW | 1983-10-14 | 56 |
| K831383 | EVENT-TEST SLIDE | JHJ | 1983-06-22 | 55 |
| K823199 | ENZYME-TEST DIGOXIN | KXT | 1982-11-29 | 34 |
| K822777 | THERAPEUTIC DRUG CONTROL | DIF | 1982-10-08 | 24 |
| K822346 | HISTIMUNE ENZYME-ANA TEST | LJM | 1982-10-08 | 63 |
| K822465 | ENZYMUNE SYSTEM I | JJE | 1982-09-14 | 29 |
| K821374 | ENZYMUNE-TEST INSULIN | CFP | 1982-05-28 | 18 |
38 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Icl Scientific.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Icl Scientific (a text match, not an official crosswalk):
Frequently asked questions
How many FDA 510(k) clearances are listed under Icl Scientific?
FDA lists 48 510(k) clearances under the applicant name “Icl Scientific” (first 1976, latest 1988), across 36 product codes in 6 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Icl Scientific?
The median time from FDA receipt to decision across 510(k)s cleared under the name Icl Scientific is 28 days.
Which FDA product codes appear under Icl Scientific?
The most frequent FDA product codes under this applicant name are DEW (Igg, Antigen, Antiserum, Control, 4); JJW (Urinalysis Controls (Assayed And Unassayed), 3); CZP (Iga, Antigen, Antiserum, Control, 2).
Next steps
- See all 48 Icl Scientific clearances with predicates and recalls
- Run predicate analysis for product code DEW, Icl Scientific's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.